PEStore

Venture Capital

Revent

Revent backs early-stage and high-growth companies, typically pre-profit, from Germany. It states a focus on healthcare & life sciences, environmental & safety and software & internet.

Disclosed holdings25
Earliest stated investment
HeadquartersGermany
Stated cheque size€500K-€3M

Portfolio

Disclosed holdings

Companies Revent lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
Apiday
App
Atmen
Atmocooling
Avelios
Carbonpool
Farmless
Forward Earth
Granular Energy
MAGNOTHERMdevelops next-generation sustainable cooling systems.
Mirantus
Netpurpose
Noscendo
Nzn2
One Five
Oska Health
Ottogroup
Portfolio companies listed by category without names
Powernaut
Resourcify
Sylvera
Tech
Techfundingnews
Tomorrow
tem.energyreshaping how renewable energy is transacted.

Compiled from Revent’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Revent?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other venture capital investors active in healthcare & life sciences.